Furthermore, mitochondrial proliferation and differentiation, primarily regulated by peroxisome proliferator-activated receptor-gamma-coactivator-1 alpha (PGC-1α), can be impaired in NASH [12]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatohepatitis.